Jennison Associates’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-122,495	Closed	-$13.1M	–	639
2023 Q1	$13.1M	Buy	122,495 +57	+0%	+$6.12K	0.01%	359
2022 Q4	$13.5M	Buy	+122,438	New	+$13.5M	0.01%	369